Qiagen

QIAGEN N.V., established in 1984, is a leading multinational life sciences and molecular diagnostics company. It develops advanced technologies enabling researchers and clinicians to derive meaningful biological insights from DNA, RNA, and protein samples. The company's extensive portfolio includes sophisticated sample preparation solutions, innovative assay technologies, and powerful bioinformatics tools, all designed to streamline molecular testing workflows for scientific research, clinical diagnostics, and applied sciences across global markets. With a revenue of $2.1B, QIAGEN serves a diverse customer base, driving progress in healthcare and scientific discovery through its innovative solutions.

Operating a network of 31 offices and regional hubs worldwide, QIAGEN employs between 5,000-10,000 professionals dedicated to advancing scientific understanding. The company's commitment to excellence is evident in its broad range of products, from essential sample preparation kits to complex assay development platforms. These tools are vital for genomics, personalized healthcare, and forensic testing, providing actionable insights for improved decision-making. Meet Qiagen's team to understand the expertise driving these critical advancements.

QIAGEN's strategic focus on molecular testing and diagnostics positions it as a key player in the healthcare and life sciences sectors. Its solutions facilitate faster, more accurate testing, contributing to better patient outcomes and accelerating scientific breakthroughs. The company's global presence ensures widespread access to its innovative technologies, supporting applications from basic research to clinical implementation. QIAGEN's ongoing investment in research and development solidifies its role as a leader in providing essential tools for understanding biological complexity and advancing human health.